NuScale Power stock jumps 15% on nuclear policy buzz — what traders watch before Tuesday’s open

NuScale Power stock jumps 15% on nuclear policy buzz — what traders watch before Tuesday’s open

New York, Jan 5, 2026, 21:41 EST — Market closed NuScale Power Corp shares jumped on Monday, with the small modular reactor developer closing up about 15% at $18.78. The move capped a second straight session of double-digit gains for the stock. Nasdaq The rally matters because NuScale and its peers live and die on regulation and capital. Any hint that Washington wants faster licensing — the process regulators use to clear a reactor design and approve a plant site — can reset sentiment quickly in a sector that remains years from broad commercial deployment. Congress.gov Traders pointed to a
Pfizer stock in the spotlight: what to watch ahead of CEO Bourla’s JPM Healthcare Conference webcast

Pfizer stock in the spotlight: what to watch ahead of CEO Bourla’s JPM Healthcare Conference webcast

New York, January 5, 2026, 21:51 EST — Market closed Pfizer said it will webcast a discussion with Chief Executive Albert Bourla at the J.P. Morgan Healthcare Conference next week, putting the drugmaker’s 2026 reset back in focus. Pfizer shares finished Monday little changed, down 0.04% at $25.17. Pfizer The San Francisco gathering is a major kickoff for healthcare investing, and it comes as Pfizer tries to convince markets it can replace fading pandemic-era revenue. The company’s initial 2026 outlook, issued in December, came in below analysts’ estimates. JPMorgan Chase That timing matters because Pfizer is navigating lower sales of
ServiceNow (NOW) stock barely moves after ex-Microsoft legal chief Nowbar is named president — here’s what investors watch next

ServiceNow (NOW) stock barely moves after ex-Microsoft legal chief Nowbar is named president — here’s what investors watch next

New York, January 5, 2026, 21:38 EST — Market closed ServiceNow on Monday named longtime Microsoft executive Hossein Nowbar as president and chief legal officer, shifting the top legal job as the company leans harder into AI and cybersecurity. Microsoft Vice Chair and President Brad Smith called Nowbar “incredibly fortunate to have him,” in a statement. ServiceNow shares closed up 0.05% at $147.52 and were little changed in extended trading, which is trading outside the 9:30 a.m. to 4 p.m. regular session. ServiceNow Newsroom+1 The move lands at a delicate moment for big enterprise software firms, which are balancing customer
6 January 2026
Thermo Fisher stock closes at a 52-week high after Evercore target raise — what to watch next for TMO

Thermo Fisher stock closes at a 52-week high after Evercore target raise — what to watch next for TMO

New York, Jan 5, 2026, 21:32 EST — Market closed Thermo Fisher Scientific Inc shares rose 3.2% to close at $611.20 on Monday, after trading between $590 and $611.60 and hitting a fresh 52-week high. Evercore ISI lifted its price target — an analyst estimate for where a stock could trade — to $650 from $610 and kept an “Outperform” rating, meaning it expects the shares to beat the broader market. Marketscreener data showed a consensus “Buy” rating and an average target price of $641.57. marketwatch.com+2Moomoo+2 The rally comes as investors position ahead of late-January earnings and look for clarity
6 January 2026
Freeport-McMoRan stock jumps near 52-week high as copper hits record — what to watch next

Freeport-McMoRan stock jumps near 52-week high as copper hits record — what to watch next

New York, January 5, 2026, 21:34 EST — Market closed Freeport-McMoRan shares ended Monday up 4.8% at $54.41, after U.S. copper prices set their first record since a summer tariff-driven spike. Wall Street Journal The move matters because Freeport’s earnings power is heavily tied to copper, a metal used in power grids, electric vehicles and data centers. When copper rises, miners’ realized prices typically improve faster than many costs, lifting margins. Copper prices vaulted to records above $13,000 a metric ton on Monday as investors weighed supply tightness and a new layer of geopolitical and trade uncertainty, Reuters reported. “Copper
6 January 2026
GE Vernova stock edges higher after Vietnam gas-plant start; Jan. 28 earnings now in focus

GE Vernova stock edges higher after Vietnam gas-plant start; Jan. 28 earnings now in focus

New York, Jan 5, 2026, 21:34 EST — Market closed GE Vernova (GEV.N) shares ended 0.2% higher on Monday after the power equipment maker said a 1.6-gigawatt liquefied natural gas (LNG) plant in Vietnam began commercial operations and flagged Jan. 28 for its next earnings release. Investing.com+2GE Vernova+2 The update matters now because investors have been bidding up power and grid suppliers on expectations that rising electricity demand will translate into years of orders. The U.S. Energy Information Administration has said U.S. electricity consumption is expected to hit record highs in 2026, driven in part by data centers. Reuters Rate
Merck stock dips after CDC vaccine overhaul puts Gardasil dosing in the spotlight

Merck stock dips after CDC vaccine overhaul puts Gardasil dosing in the spotlight

New York, January 5, 2026, 21:32 (EST) — Market closed Merck & Co shares dipped in late trading on Monday after U.S. health officials rewrote the childhood and adolescent immunization schedule, including a change to a one-dose recommendation for the human papillomavirus (HPV) vaccine. Merck (MRK.N) closed up 0.93% at $107.44 and was last down 0.22% at $107.20 after the bell. Yahoo Finance The shift matters for Merck because Gardasil 9 is the only HPV vaccine available for use in the United States, and the CDC’s guidance helps shape how physicians counsel families. Even modest changes in dosing guidance can
Nu Holdings stock jumps 5% to near $18 — what’s driving NU and what investors watch next

Nu Holdings stock jumps 5% to near $18 — what’s driving NU and what investors watch next

New York, Jan 5, 2026, 21:21 EST — Market closed Nu Holdings Ltd (NU.N), the parent of Brazilian digital lender Nubank, gained 5.4% on Monday to about $17.94 after trading between $17.02 and $18.14. Volume topped 74 million shares. The move matters now because NU is pushing into the $18 handle just as investors start to price in the first wave of quarterly results and recalibrate risk after a strong 2025 run for equities. It also leaves the stock closer to where many analysts peg fair value, raising the bar for the next catalyst to keep the rally intact. Financial
AbbVie stock slides 4% as pharma lags Wall Street rally — what investors watch next for ABBV

AbbVie stock slides 4% as pharma lags Wall Street rally — what investors watch next for ABBV

New York, Jan 5, 2026, 21:27 EST — Market closed AbbVie Inc shares closed down 4% on Monday at $220.18, lagging a Wall Street rally that pushed the Dow to a record high. The move mattered because drug and biotech names were among the day’s laggards as investors rotated into energy and financials after Venezuela headlines lifted oil-linked stocks. The NYSE Arca Pharmaceutical Index fell about 1.4% and the SPDR S&P Biotech ETF slid 1.1%, while the Health Care Select Sector SPDR ETF dipped 0.3%. Yahoo Finance AbbVie also put a near-term spotlight on its calendar, saying it will present
P&G stock slides again after Wells Fargo cuts target — what investors watch next

P&G stock slides again after Wells Fargo cuts target — what investors watch next

NEW YORK, January 5, 2026, 21:15 EST — Market closed Procter & Gamble (PG.N) shares ended down about 1% on Monday at $140.37 after Wells Fargo cut its price target to $158 from $170 and kept an Overweight rating on the stock. TipRanks The move marked P&G’s fifth straight daily decline and left the stock about 22% below its 52-week high. Trading volume was about 12.1 million shares, above its 50-day average of 9.6 million. marketwatch.com The slide came on a strong day for the broader market, with the S&P 500 up 0.64% and the Dow up 1.23%. P&G also
6 January 2026
GE Aerospace stock hits a fresh high — what investors are watching before earnings

GE Aerospace stock hits a fresh high — what investors are watching before earnings

New York, January 5, 2026, 21:05 EST — Market closed GE Aerospace (NYSE: GE) shares closed up 1.1% at $324.32 on Monday, setting a new 52-week high after two straight gains. Volume ran above its 50-day average, even as the move trailed bigger gains in Honeywell. The record close matters because GE has become a crowded proxy for the commercial aviation upcycle, where engine makers collect much of their profit after the sale. The “aftermarket” is the parts-and-maintenance business tied to engines already flying, and it tends to be steadier than new-aircraft production. That durability will be tested soon. GE
Salesforce stock rises as RBC lifts target; $250 level and jobs report loom

Salesforce stock rises as RBC lifts target; $250 level and jobs report loom

New York, Jan 5, 2026, 21:06 EST — Market closed Salesforce shares rose 1.1% to $256.26 on Monday, snapping a three-session slide. The customer-relationship-management software maker is still about 30% below its 52-week high and traded lighter-than-average volume, according to MarketWatch data. marketwatch.com The move comes as Wall Street tries to pin down which large-cap software names can turn “AI agents” — software that can take actions on a user’s behalf — into billable growth. RBC Capital Markets analyst Rishi Jaluria raised his price target on Salesforce to $290 from $250 and kept a Sector Perform rating, roughly a hold

Stock Market Today

Pfizer stock price rises into weekend as FDA priority review, TrumpRx discounts grab focus

Pfizer stock price rises into weekend as FDA priority review, TrumpRx discounts grab focus

7 February 2026
New York, February 7, 2026, 05:48 EST — Market closed Pfizer Inc (PFE) shares ended Friday up 2.8% at $27.22, after trading between $26.52 and $27.37. About 50.7 million shares changed hands. (Yahoo Finance) The stock’s late-week lift comes with a key regulatory clock running: the FDA granted priority review for Pfizer’s supplemental filing to broaden use of its hemophilia drug Hympavzi, with a target decision deadline in the second quarter. Priority review shortens the agency’s standard review timeline by four months. “There is a significant medical need for younger patients with hemophilia and for those who have developed inhibitors,”
Go toTop